Association of environmental and meteorological factors on the spread of COVID-19 in Victoria, Mexico, and air quality during the lockdown.

This study aims to analyze the correlation between environmental factors and confirmed cases of COVID-19 pandemic in Victoria, Mexico. The analysis is performed at the micro-level, filtering only confirmed cases of COVID-19 that are located near air quality monitoring stations, within an approximate coverage of 2.5 km, in order to identify a possible specific association between PM2.5, PM10, carbon monoxide (CO), relative humidity, temperature, absolute humidity, and total confirmed cases of COVID-19. The results evidenced that the cases of COVID-19 were very strongly associated with CO concentration. Our results also suggested that particulate matter pollution (PM2.5 and PM10) exposure have a significant correlation for confirmed cases of COVID-19. Furthermore, we studied the changes in air quality during the COVID-19 outbreak by comparing the average concentration of the four weeks before lockdown (February 16 to March 14, 2020) and the following twelve weeks during the partial lockdown (March 15 to June 06, 2020), revealing a very significant decrease of pollutants.

Particulate matter 1µm (PM1) dataset collected by low-cost sensors in residential and industrial areas at the neighborhood level.

The incursion of low-cost sensors (LCS) for monitoring particulate matter in different fractions of particles (PM10, PM2.5, and PM1) allows the characterization of the concentration levels of specific sources or events, including the analysis of ultrafine fractions (PM1). Several studies have documented adverse effects on human health due to exposure to PM1, such as morbidity and mortality from respiratory, cardiovascular, and, in some cases, carcinogenic diseases. Hence, studying the concentration levels and the sources that cause PM1 is imperative. LCS is an alternative to understanding contaminant concentration levels by considering spatial and temporal community dynamics by monitoring critical zones. Furthermore, collecting and managing large amounts of data through automatic processing and analysis generates information to support decision-making to reduce exposure and risks to people's health. The dataset presents the concentration level of PM1 (µg/m3) calculated from the particles of size 0.03 µm, 0.05 µm, and 1.0 µm recorded and counted by the sensor in a sample per minute for 24 h for seven continuous days. The values of the meteorological factors of relative humidity, temperature, and heat index complement these attributes. The dataset comprises records collected (in the same period) at four particulate matter monitoring stations, which compose an LCS network supported by Internet of Things (IoT) technologies. The data collection points were located in different areas of Reynosa, Mexico, considering strategic places for monitoring environmental pollution, such as industrial parks, residential areas, avenues with high vehicular traffic and transportation of heavy cargo, and an airport.

Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina.

BACKGROUND: Despite the economic burden of psoriasis for patients and societies, scant information exists regarding the impact and burden of the disease in Argentina. OBJECTIVE: The objective of this study was to estimate medical resource consumption and direct health care costs for patients with moderate/severe psoriasis in Buenos Aires, Argentina from the perspective of the payer. METHODS: Adults with moderate/severe psoriasis (severity was defined as receiving systemic treatment), during January 2010-January 2014, aged 18 years and older, members of the Italian Hospital Medical Care Program with at least 18 months of follow-up were included. All data on hospitalizations, drug prescription, outpatient episodes, consultations, and investigations/tests in the 12 months before inclusion in the study were considered for the estimation of medical resource consumption and direct health care costs. First-quarter 2018 costs were obtained from the IHMCP and converted into US dollars (using the January 2018 exchange rate). RESULTS: A total of 791 patients were included. The mean age at diagnosis was 34±12 years. Almost 65% of the patients had a dermatologist as their usual source of care, 43% had internists, and 14% had rheumatologists. The average yearly direct cost was US$ 5326 (95% CI: 4125-7896) per patient per year. STUDY LIMITATION: The single center design and the retrospective nature are the main limitations. CONCLUSION: This is the first Argentine study that evaluated the costs of moderate/severe psoriasis by taking into consideration the direct medical costs of the disease.

Association Between Pulmonary Embolism and COVID-19 in Emergency Department Patients Undergoing Computed Tomography Pulmonary Angiogram: The PEPCOV International Retrospective Study.

BACKGROUND: There have been reports of procoagulant activity in patients with COVID-19. Whether there is an association between pulmonary embolism (PE) and COVID-19 in the emergency department (ED) is unknown. The aim of this study was to assess whether COVID-19 is associated with PE in ED patients who underwent a computed tomographic pulmonary angiogram (CTPA). METHODS: A retrospective study in 26 EDs from six countries. ED patients in whom a CTPA was performed for suspected PE during a 2-month period covering the pandemic peak. The primary endpoint was the occurrence of a PE on CTPA. COVID-19 was diagnosed in the ED either on CT or reverse transcriptase-polymerase chain reaction. A multivariable binary logistic regression was built to adjust with other variables known to be associated with PE. A sensitivity analysis was performed in patients included during the pandemic period. RESULTS: A total of 3,358 patients were included, of whom 105 were excluded because COVID-19 status was unknown, leaving 3,253 for analysis. Among them, 974 (30%) were diagnosed with COVID-19. Mean (±SD) age was 61 (±19) years and 52% were women. A PE was diagnosed on CTPA in 500 patients (15%). The risk of PE was similar between COVID-19 patients and others (15% in both groups). In the multivariable binary logistic regression model, COVID-19 was not associated with higher risk of PE (adjusted odds ratio = 0.98, 95% confidence interval = 0.76 to 1.26). There was no association when limited to patients in the pandemic period. CONCLUSION: In ED patients who underwent CTPA for suspected PE, COVID-19 was not associated with an increased probability of PE diagnosis. These results were also valid when limited to the pandemic period. However, these results may not apply to patients with suspected COVID-19 in general.

Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina,

Abstract Background: Despite the economic burden of psoriasis for patients and societies, scant information exists regarding the impact and burden of the disease in Argentina. Objective: The objective of this study was to estimate medical resource consumption and direct health care costs for patients with moderate/severe psoriasis in Buenos Aires, Argentina from the perspective of the payer. Methods: Adults with moderate/severe psoriasis (severity was defined as receiving systemic treatment), during January 2010-January 2014, aged 18 years and older, members of the Italian Hospital Medical Care Program with at least 18 months of follow-up were included. All data on hospitalizations, drug prescription, outpatient episodes, consultations, and investigations/tests in the 12 months before inclusion in the study were considered for the estimation of medical resource consumption and direct health care costs. First-quarter 2018 costs were obtained from the IHMCP and converted into US dollars (using the January 2018 exchange rate). Results: A total of 791 patients were included. The mean age at diagnosis was 34 ± 12 years. Almost 65% of the patients had a dermatologist as their usual source of care, 43% had internists, and 14% had rheumatologists. The average yearly direct cost was US$ 5326 (95% CI: 4125-7896) per patient per year. Study limitation: The single center design and the retrospective nature are the main limitations. Conclusion: This is the first Argentine study that evaluated the costs of moderate/severe psoriasis by taking into consideration the direct medical costs of the disease.